| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/20/1994 | WO1994001553A1 Receptor derivates with binding sites for human rhinoviruses |
| 01/20/1994 | WO1994001550A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | WO1994001545A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena |
| 01/20/1994 | WO1994001533A1 Deletion mutants as vaccines for cholera |
| 01/20/1994 | WO1994001462A1 Biologically active polypeptides derived from an actinomycete |
| 01/20/1994 | WO1994001459A1 A fungicidally active compound |
| 01/20/1994 | WO1994001443A1 Therapeutic nucleosides |
| 01/20/1994 | WO1994001414A1 Uracil derivatives as enzyme inhibitors |
| 01/20/1994 | WO1994001404A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001134A1 Parenteral immunization against rotavirus |
| 01/20/1994 | WO1994001131A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | WO1994001130A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | WO1994001127A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | WO1994001121A1 Biocidal composition containing mustard seed plant extract |
| 01/20/1994 | WO1994001110A1 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS) |
| 01/20/1994 | WO1994001102A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | DE4323567A1 Hepatitis B viral infection treatment compsn. - contg. iridoid glycoside or aglycone, e.g. aucubin as low toxicity viral DNA replication inhibitor |
| 01/20/1994 | CA2140150A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | CA2140140A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2139837A1 A fungicidally active compound |
| 01/20/1994 | CA2139836A1 Iracil derivatives as enzyme inhibitors |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139349A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | CA2139345A1 New biologically active polypeptides; preparation and use |
| 01/20/1994 | CA2139319A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | CA2139132A1 Therapeutic nucleosides |
| 01/20/1994 | CA2136324A1 5'-indolinyl oxazolidinones useful against mycobacterium tuberculosis |
| 01/20/1994 | CA2118586A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | CA2117099A1 Receptor derivatives having binding sites for human rhinoviruses |
| 01/20/1994 | CA2116971A1 Parenteral immunization against rotavirus |
| 01/19/1994 | EP0579488A1 Composition for treating mastitis and metritis |
| 01/19/1994 | EP0579421A2 Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process |
| 01/19/1994 | EP0579333A2 Antibacterial antiplaque oral composition |
| 01/19/1994 | EP0579223A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity |
| 01/19/1994 | EP0578965A1 Compositions and methods for treating gastrointestinal disorders |
| 01/19/1994 | EP0578818A1 Immunotherapy for recurrent hsv infections |
| 01/19/1994 | EP0578817A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 01/19/1994 | EP0578776A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences |
| 01/19/1994 | EP0578745A1 Phosphorus containing compounds as inhibitors of retroviruses |
| 01/19/1994 | EP0578733A1 Use of riboflavin in the treatment of hiv, herpes virus, retinitis pigmentosa and malaria related deseases |
| 01/19/1994 | EP0578687A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 01/19/1994 | EP0504307B1 Method of treating septic shock |
| 01/19/1994 | EP0439453B1 Improved method for treatment of gastrointestinal disorders |
| 01/19/1994 | CN1080957A A dna sequence and encoded peptide useful in the diagnostics of hepatites disease |
| 01/19/1994 | CN1080926A Cyclic peptide antifungal agents and process for preparation thereof |
| 01/19/1994 | CN1080920A Novel uqinoline derivatives and processes for preparing the same |
| 01/19/1994 | CN1080853A Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 01/19/1994 | CN1023561C Process for preparing aristeromycin/adenosine derivatives |
| 01/18/1994 | US5280111 Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients |
| 01/18/1994 | US5280107 Using an anioic exchanger |
| 01/18/1994 | CA2100642A1 Carboxylic acid derivatives |
| 01/18/1994 | CA1326237C Therapeutic nucleosides |
| 01/18/1994 | CA1326211C Antibiotic solutions and the lyophilization thereof |
| 01/18/1994 | CA1326209C Glass microbeads having bacteriostatic properties and process for manufacturing such microbeads |
| 01/17/1994 | CA2100274A1 Pradimic acids, amides, and novel pradimicin derivatives |
| 01/14/1994 | CA2098033A1 Process for preparing cyclobutane purines |
| 01/12/1994 | EP0578231A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with beta-cyclodextrines |
| 01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/12/1994 | EP0577894A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 01/12/1994 | EP0577760A1 Sequential dosing of antifungal and antiinflammatory compositions |
| 01/12/1994 | EP0577646A1 Sustained release drug delivery devices |
| 01/12/1994 | EP0330661B1 Fusion proteins and particles |
| 01/12/1994 | EP0329671B1 Particulate hybrid hiv antigens |
| 01/12/1994 | CN1080634A Cyclopentane-and-pentene-b-amino acids |
| 01/11/1994 | US5278317 Optically pure R-enantiomer of alpha,alpha-dilower alkyl-pyrrolidine-3-methane amines |
| 01/11/1994 | US5278288 Contacting milk raw materials containing the glycomacropeptide with cation exchanger to adsorb a fraction of the material, collecting a nonadsorbed fraction, concentrating and desalting the fraction |
| 01/11/1994 | US5278184 Synthetic derivatives of pyrrole and pyrrolidine suitable for the therapy of infections caused by rhinoviruses |
| 01/11/1994 | US5278171 Anticholesterol, antilipemic agents |
| 01/11/1994 | US5278067 Culture product of microorganism Phoma |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA1326037C Strobilurine derivatives, their preparation and their use |
| 01/11/1994 | CA1326026C Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient |
| 01/11/1994 | CA1325973C Cyclosporin-containing pharmaceutical composition |
| 01/09/1994 | CA2100045A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic .beta. - cyclodextrin derivatives, a proce ss for the preparation thereof and the use thereof |
| 01/06/1994 | WO1994000586A2 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 01/06/1994 | WO1994000575A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | WO1994000509A1 Oxazolone derived materials |
| 01/06/1994 | WO1994000493A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | WO1994000467A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | WO1994000457A1 Alphalosporins and 1-carba-1-dethia cephalosporins |
| 01/06/1994 | WO1994000161A1 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids |
| 01/06/1994 | WO1994000151A1 Combinatorial polypeptide antigens |
| 01/06/1994 | WO1994000150A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 01/06/1994 | WO1994000147A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
| 01/06/1994 | WO1994000142A1 Emulsified preparation of aureobasidin |
| 01/06/1994 | WO1994000137A1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
| 01/06/1994 | WO1994000131A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | WO1994000011A1 Starch-iodine-peroxide preservation of blood, tissues and biological fluids |
| 01/06/1994 | WO1993016726A3 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2139350A1 Oxazolone derived materials |
| 01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | CA2138996A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | CA2138970A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | CA2138770A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | CA2138281A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | CA2137674A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |